Valiant Laboratories Limited is a pharmaceutical ingredient and bulk drug manufacturing company based in India, with operations extending globally. The company produces paracetamol in various grades, including those meeting the standards of Indian, British, European, and United States pharmacopeias, to address conditions such as headaches, muscle aches, arthritis, backaches, toothaches, colds, and fevers. In addition to its pharmaceutical offerings, Valiant Laboratories Limited also provides specialty chemicals. Originally named Bharat Chemicals, the company underwent a name change to Valiant Laboratories Limited in August 2021. Established in 1980 and headquartered in Mumbai, India, the company operates as a subsidiary of Dhanvallabh Ventures LLP.
Valiant Laboratories Limited
- 111.70 -1.27(-1.12%) 113.00 0.00(0.00%)
Live Valiant Laboratories Limited Share Price Chart
Valiant Laboratories Limited Share Performance
| Today's Low | Today's High | |
|---|---|---|
| 111.02 110.95 | 113.99 114.50 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 99.10 (13-Jan-2025) 99.35 (13-Jan-2025) | 214.95 (02-Feb-2024) 226.95 (02-Feb-2024) |
- Open
- 113.00 114.50
- Previous Close
- 112.97 113.00
- Volume
- 0.07
- Total Traded value
- 0.08 (Lakhs)
- Upper circuit
- 135.56 209.45
- Lower circuit
- 90.37 139.65
Valiant Laboratories Limited Share Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 38,102 | 22,124 |
| Bid Price | Quantity |
|---|---|
| 111.69 | 5.00 |
| 111.64 | 15.00 |
| 111.63 | 34.00 |
| 111.61 | 20.00 |
| 111.58 | 43.00 |
| Total: | 38,102 |
| Ask Price | Quantity |
|---|---|
| 112.19 | 32.00 |
| 112.23 | 34.00 |
| 112.24 | 5.00 |
| 112.29 | 5.00 |
| 112.33 | 1.00 |
| Total: | 22,124 |
Valiant Laboratories Limited Share Fundamentals
| Market Cap: | 4.85 Cr |
| PE Ratio (TTM): | -41.85 |
| PB Ratio: | 2.14 |
| Industry P/E: | 0.00 |
| Debt to Equity: | - |
| ROE: | -5.09 |
| EPS (TTM): | -2.70 |
| Book Value: | 0.00 |
| Face Value: | 10.00 |
Valiant Laboratories Limited Stock Financials
| Sep, 2023 | Sep, 2023 | Sep, 2023 | Sep, 2022 | Sep, 2023 | |
|---|---|---|---|---|---|
| Revenue | 1,842.05 Cr | 9.50 Cr | 99.38 Cr | 159.47 Cr | 59.55 Cr |
| Profit | 270.08 Cr | 5.65 Cr | 10.85 Cr | 14.93 Cr | 0.79 Cr |
| Expense | - | 13.47 Cr | 85.18 Cr | 140.91 Cr | 61.44 Cr |
| Comprehensive income | - | 5.65 Cr | 11.09 Cr | 14.93 Cr | 0.97 Cr |
| EPS | 6.00 | 0.36 | 10.03 | 13.81 | 0.24 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Valiant Laboratories Limited | Oct, 2023 Oct, 2023 | Pharmaceuticals Commodity Chemicals | VALIANTLAB VALIANTLAB |
Valiant Laboratories Limited Stock Shareholding pattern
Sep, 2023 Oct, 2023
Valiant Laboratories Limited Share FAQ's
What is the range of today's stock performance for Valiant Laboratories Limited?
Today's stock performance witnessed a fluctuation from a minimum of 111.02 on the NSE (National Stock Exchange) to a maximum of 113.99. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 110.95 to a high of 114.50.
What are the 52-week low and high values for Valiant Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 99.10 (occurred on 13-Jan-2025) and a high of 214.95 (achieved on 02-Feb-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 99.35 (on 13-Jan-2025), and the 52-week high is 226.95 (on 02-Feb-2024).
What was the opening and previous closing prices for Valiant Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 99.10 (occurred on 13-Jan-2025) and a high of 214.95 (achieved on 02-Feb-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 99.35 (on 13-Jan-2025), and the 52-week high is 226.95 (on 02-Feb-2024).
What is the total volume and traded value for Valiant Laboratories Limited for the day?
The total volume is 0, and the total traded value is 0.08 ( Lakhs).
What are the upper and lower circuit limits for Valiant Laboratories Limited?
The upper circuit limit is 135.56, and the lower circuit limit is 90.37.
What is the market cap and PE ratio for Valiant Laboratories Limited?
The market cap is 4.85 Cr, and the PE ratio (TTM) is 0.00.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Valiant Laboratories Limited?
ROE is -5.09, EPS is -2.70, book value is not available
What are the revenue and profit figures for the latest quarter and previous quarters for Valiant Laboratories Limited?
In Sep 2023, Revenue is 18420500000.00, and Profit is 2700800000.00. In Sep 2023, Revenue is 95020000.00, and Profit is 56540000.00.
When was Valiant Laboratories Limited listed, and what industry does it belong to?
The company, Valiant Laboratories Limited, was listed in Oct 2023 and belongs to the Pharmaceuticals industry. Its NSE symbol is VALIANTLAB.
What is the current shareholding pattern of the Valiant Laboratories Limited?
As of latest available update, promoters hold 74.94%, the public holds 25.06%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 35
- Threads
- 182
